Search Results
Mar 03, 2026, 08:05 ET LearnWorlds reveals 87% of customer teams use AI despite 42% having no strategic owner
known B2B company can outperform a global enterprise in AI-powered learning not because of budget, but because of structure," said Panos Siozos, PhD, Co-founder and CEO at LearnWorlds. "The teams pulling ahead treat AI as infrastructure with clear ownership, documented workflows, and quality guardrails.
More news about: LearnWorlds
Mar 03, 2026, 08:01 ET Vibrant Emotional Health Names Laura Gilman Chief Development Officer Amid Growing Demand for Mental Health Care
partnerships, paired with her strategic vision and fundraising leadership, is essential as Vibrant continues to scale its impact," said Jennifer Ashley, PhD, Chair of Vibrant's Board of Directors."An early chapter of my career taught me that philanthropy, when done thoughtfully, can fundamentally
More news about: Vibrant Emotional Health
Mar 03, 2026, 07:30 ET Keenova Publishes XIAFLEX® (collagenase clostridium histolyticum) Analysis in Journal of Hand Surgery Global Online
Peimer, MD; Marie A. Badalamente, PhD; Philip Blazar, MD; Keith A. Denkler, MD; William Dzwierzynski, MD; Mark Elzik, MD; F. Thomas D. Kaplan, MD; Jason A. Nydick, DO; Gary M. Pess, MD; James Verheyden, MD; Mark A. Vitale, MD; Jeffrey Andrews, MS; Qinfang Xiang, PhD; David Hurley, MD; Lawrence C. Hurst,
More news about: Keenova Therapeutics
Mar 03, 2026, 07:00 ET SpliSense Granted EMA EARLY PRIME Designation for SPL84 in Cystic Fibrosis
for such therapies."This PRIME designation represents a major regulatory milestone for SpliSense and for the SPL84 program," said Gili Hart, PhD, Chief Executive Officer of SpliSense. "It reflects the strength of our mechanistic, non-clinical and emerging clinical data, and reinforces the potential
More news about: Splisense
Mar 02, 2026, 17:32 ET Newer groundwater associated with higher risk of Parkinson's disease
transports groundwater."One way to examine our exposure to modern pollution is through our drinking water," said study author Brittany Krzyzanowski, PhD, of Atria Research Institute in New York City who conducted this research while at Barrow Neurological Institute in Phoenix, Arizona, and is a member
More news about: American Academy of Neurology
Mar 02, 2026, 17:00 ET Congruence and Ono Pharma Expand Multi-Target Research Partnership with the Addition of Two New Programs
difficult-to-drug cancer target. "We are excited to expand our partnership with Ono, a global pioneer of innovative medicines," said Sharath Hegde PhD, Chief Scientific Officer of Congruence. "The expansion is a testament to the significant contributions we have made in our existing collaboration as
More news about: Congruence Therapeutics
Mar 02, 2026, 12:08 ET The Inner Circle acknowledges Catherine A. Oleksiw, Ph.D., PCC as a Pinnacle Lifetime Member
multimedia:https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-catherine-a-oleksiw-phd-pcc-as-a-pinnacle-lifetime-member-302701213.htmlSOURCE
More news about: The Inner Circle
Mar 02, 2026, 10:35 ET Cell-free DNA offers early warning for bloodstream infections in kids with leukemia
Joshua Wolf, PhD, MBBS, St. Jude
More news about: St. Jude Children's Research Hospital
Mar 02, 2026, 10:29 ET XtalPi's AI + Robotics Platform Powers First Clinical Milestone for ReviR's Rare Neurological Drug RTX-117
dosing in our first-in-human study, coupled with the dual IND clearance in China, marks a transformative leap for ReviR Therapeutics," added Peng Yue, PhD, CEO of ReviR. "By leveraging our VoyageR AI platform and our integrated cross-border operations in the U.S. and China, we are accelerating the development
More news about: XtalPi
Mar 02, 2026, 09:49 ET The Sigourney Award-2026 Now Accepting Applications for Psychoanalytic Innovation
work submitted continues to impress our judges. Each body of work positively enhances our world and enhances the lives we lead," says Robin A. Deutsch, PhD, Analyst Trustee.The independent award celebrates both traditional and non-traditional applications of psychoanalysis. An anonymous panel of international
More news about: The Sigourney Award
Mar 02, 2026, 09:49 ET The Sigourney Award-2026 Now Accepting Applications for Psychoanalytic Innovation
work submitted continues to impress our judges. Each body of work positively enhances our world and enhances the lives we lead," says Robin A. Deutsch, PhD, Analyst Trustee.The independent award celebrates both traditional and non-traditional applications of psychoanalysis. An anonymous panel of international
More news about: The Sigourney Award
Mar 02, 2026, 09:49 ET El Premio Sigourney 2026 ahora acepta solicitudes para innovación psicoanalítica
impresionando a nuestros jueces. Cada cuerpo de trabajo mejora positivamente nuestro mundo y mejora las vidas que llevamos ", dice Robin A. Deutsch, PhD, analista fiduciario.El premio independiente celebra las aplicaciones tradicionales y no tradicionales del psicoanálisis. Un panel anónimo de
More news about: The Sigourney Award
Mar 02, 2026, 09:00 ET ReviR Therapeutics Announces First Participant Dosed in Phase 1 Study and Secures CDE Clearance for Two Orphan Indications in China, Supporting Future U.S. Expansion Strategy
fatal outcomes."The milestone is a testament to the rigor of our preclinical data and the efficiency of our global team," said Paul August, PhD, Chief Scientific Officer of ReviR. "We are committed to working closely with clinical investigators and patient organizations in China to bring these
More news about: ReviR Therapeutics
Mar 02, 2026, 08:22 ET Pioneering Investigator Dr. Dimitra Skondra Appointed Vice Chair of Research for Ophthalmology
March 2, 2026 /PRNewswire/ -- NYU Grossman School of Medicine's Department of Ophthalmology has appointed Dimitra Skondra, MD, PhD, a distinguished retinal specialist and translational researcher, as vice chair of research.
More news about: NYU Grossman School of Medicine and NYU Langone Health
Mar 02, 2026, 08:15 ET Dictionary.com's 2026 Winter Word Drop Embraces Innovation, Goes Global and Enters the Chat
and cultural exchange."English has historically expanded during periods of significant scientific and cultural change," said Steve Johnson, PhD, Director of Lexicography for the Dictionary Media Group at IXL Learning. "This update illustrates how AI innovation, conversations about health,
More news about: IXL Learning
Mar 02, 2026, 08:03 ET Decentralized Clinical Trial Validates Novel "Fasting Mimetic" Formulation for Cardiometabolic Health
intervention like this typically requires a controlled clinical setting, but we wanted to prove efficacy in the real world," said Dr. Chris Rhodes, PhD, CEO of Mimio Health. "People Science allowed us to conduct a rigorous, gold-standard trial directly in participants' homes. The data we gathered
More news about: People Science, Inc.
Mar 02, 2026, 08:02 ET Mimio Health Announces Breakthrough Clinical Trial Of Its Fasting Mimetic, Demonstrating Fasting-Like Benefits Without Dietary Changes
mimetic formulation can deliver similar metabolic, cellular, and appetite-regulating benefits as fasting – without fasting," said Dr. Chris Rhodes, PhD, CEO and Co-Founder of Mimio Health. "We observed significant improvements in cholesterol and glucose metabolism, oxidative stress, digestion, and
More news about: Mimio Health, Inc.
Mar 02, 2026, 02:13 ET DentScribe Receives Notice of Allowance for First U.S. Patent, Validating Its Agentic AI Platform for Dentistry
production."Most systems capture words. This invention protects a system that captures clinical intent and operationalizes it," said Dr. Ratinder Paul Ahuja, PhD, Board Chair of DentScribe. "As an inventor, I'm excited by the scope and rigor of what's been allowed: real-time, schema-driven clinical extraction,
More news about: DentScribe
Mar 02, 2026, 02:00 ET Bracco Announces EU Launch of AiMIFY® and Expands AI Portfolio with Avicenna.AI Partnership at ECR 2026
was designed to maximize diagnostic information from contrast-enhanced MRI while preserving standard of practice," said Ajit Shankaranarayanan, PhD, Chief Product Officer, Subtle Medical. "The European launch in collaboration with Bracco marks an important milestone in expanding access to AI-enhanced
More news about: Bracco Group
Feb 27, 2026, 17:51 ET Empowering People and Elevating Performance: Wellness Workdays Announces 2026 Conference Speakers
NowDuane Jourdeans, Founder of Upward Spiral Consulting - Meaningful Micro Moments: Creating Everyday Well-BeingDr. Sarah Porter, PhD, Licensed Psychologist - The Motivation Multiplier: Unlock Employee Engagement and Banish Burnout with Psychological ScienceDr. James
More news about: Wellness Workdays
Feb 27, 2026, 15:51 ET NUNM Receives $1.5 Million Gift to Support Campus Expansion, Future Integrative Medicine Center
education for students.The gift reflects a longstanding family commitment to naturopathic medical education. Shelley's mother, Kathleen Shelley, PhD, contributed to national efforts supporting federal recognition of the Council on Naturopathic Medical Education, helping advance professional accreditation
More news about: National University of Natural Medicine
Feb 27, 2026, 09:15 ET Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
today and clinical whole-genome testing provides a transformative opportunity to end the diagnostic odyssey for patients," said Eric Green, MD, PhD, chief medical officer of Illumina. "Our colleagues at IPRD will now be equipped to break diagnostic barriers, and we are proud to help them accelerate
More news about: Illumina, Inc.
Feb 27, 2026, 08:11 ET Lilly's Olumiant (baricitinib) recommended by CHMP for approval of expanded use in the European Union for adolescents with severe alopecia areata
manage and occurs at a time when appearance can have a significant impact on social identity and emotional well-being," said Thierry Passeron, M.D., PhD, professor and chair, Department of Dermatology, Université Côte d'Azur. "In clinical practice, families are frequently left with limited options that
More news about: Eli Lilly and Company
Feb 27, 2026, 04:11 ET WuXi XDC Enters Strategic Collaboration with Earendil Labs on WuXiTecan-2 Payload-Linker Technology Platform
submissions, and commercialization. This complementary partnership ensures maximized resource utilization and efficient project progression.Jimmy Li, PhD, CEO of WuXi XDC, stated, "We are very pleased to establish this strategic partnership with Earendil Labs. This collaboration not only fully demonstrates
More news about: WuXi XDC
Feb 27, 2026, 02:00 ET Earendil Labs Enters Strategic Collaboration with WuXi XDC on WuXiTecan-2 Payload-Linker Technology Platform
submissions, and commercialization. This complementary partnership ensures maximized resource utilization and efficient project progression.Jian Peng, PhD, CEO of Earendil Labs, said, "Partnering with WuXi XDC represents a critical step in our mission to transform biopharmaceutical R&D through AI. WuXi
More news about: Earendil Labs